EVERYTHING ABOUT BLOCK PAIN RECEPTORS WITH PROLEVIATE

Possessing determined the palmitoylation motif of APLNR, we made a short substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This aggressive peptide, which targets the APLNR palmitoylation web page in combination with morphine, can inhibit the development of NCP, such as pain incidence, microglial activation, and inf